Patient case study: Navigating treatment options for HR+/HER2- Early Breast Cancer
Recorded Courses
hosted bySpringer Healthcare IME
hosted bySpringer Healthcare IME
attend it anywhere online
category
Medicine
Oncology
price
Free
speakers
Patient case study: Navigating treatment options for HR+/HER2- Early Breast Cancer is organized by Springer Healthcare IME.
Description:
In this case study module, Roberto Hegg discusses the current treatment guidelines and emerging therapies for HR+/HER2- early breast cancer, and the most appropriate management approaches based on the identified recurrence risk factors, with reference to the treatment of a 43-year old HR+/HER2- early breast cancer patient.
Learning objectives:
After completing this activity, you will be able to:
- Describe the most appropriate first-line treatment options based on risk of recurrence
- Explain the most appropriate subsequent-line treatment options based on residual risk